Ancker OV, Kruger M, Wehland M, Infanger M, Grimm D (2019) Multikinase inhibitor treatment in thyroid Cancer. Int J Mol Sci 21(1). https://URL.org/10.3390/ijms21010010

Kim J, Gosnell JE, Roman SA (2020) Geographic influences in the global rise of thyroid cancer. Nat Rev Endocrinol 16(1):17–29. https://URL.org/10.1038/s41574-019-0263-x

Article  PubMed  Google Scholar 

Prete A, Borges de Souza P, Censi S, Muzza M, Nucci N, Sponziello M (2020) Update on fundamental mechanisms of thyroid Cancer. Front Endocrinol (Lausanne) 11:102. https://URL.org/10.3389/fendo.2020.00102

Article  PubMed  Google Scholar 

Wang J, Zhanghuang C, Jin L et al (2022) Development and validation of a nomogram to predict cancer-specific survival in elderly patients with papillary thyroid carcinoma: a population-based study. BMC Geriatr 22(1):736. https://URL.org/10.1186/s12877-022-03430-8

Article  PubMed  PubMed Central  Google Scholar 

Wang Y, Yang J, Chen S, Wang W, Teng L (2022) Identification and validation of a Prognostic signature for thyroid Cancer based on ferroptosis-related genes. Genes (Basel) 13(6). https://URL.org/10.3390/genes13060997

Fiore M, Oliveri Conti G, Caltabiano R et al (2019) Role of emerging environmental risk factors in thyroid Cancer: a brief review. Int J Environ Res Public Health 16(7). https://URL.org/10.3390/ijerph16071185

Jin M, Li Z, Sun Y et al (2021) Association analysis between the interaction of RAS family genes mutations and papillary thyroid carcinoma in the Han Chinese population. Int J Med Sci 18(2):441–447. https://URL.org/10.7150/ijms.50026

Article  PubMed  PubMed Central  Google Scholar 

Abdullah MI, Junit SM, Ng KL, Jayapalan JJ, Karikalan B, Hashim OH (2019) Papillary thyroid Cancer: genetic alterations and molecular Biomarker investigations. Int J Med Sci 16(3):450–460. https://URL.org/10.7150/ijms.29935

Article  PubMed  PubMed Central  Google Scholar 

Dheer D, Nicolas J, Shankar R (2019) Cathepsin-sensitive nanoscale drug delivery systems for cancer therapy and other diseases. Adv Drug Deliv Rev 151–152:130–151. https://URL.org/10.1016/j.addr.2019.01.010

Article  PubMed  Google Scholar 

Petushkova AI, Savvateeva LV, Korolev DO, Zamyatnin AA Jr. (2019) Cysteine cathepsins: potential applications in Diagnostics and Therapy of Malignant tumors. Biochem (Mosc) 84(7):746–761. https://URL.org/10.1134/S000629791907006X IF: 2.3 Q3 B4

Article  Google Scholar 

Khaket TP, Kwon TK, Kang SC (2019) Cathepsins: potent regulators in carcinogenesis. Pharmacol Ther 198:1–19. https://URL.org/10.1016/j.pharmthera.2019.02.003

Article  PubMed  Google Scholar 

Xiao Y, Cong M, Li J et al (2021) Cathepsin C promotes breast cancer lung metastasis by modulating neutrophil infiltration and neutrophil extracellular trap formation. Cancer Cell 39(3):423–437e7. https://URL.org/10.1016/j.ccell.2020.12.012

Article  PubMed  Google Scholar 

Wu N, Wang Y, Wang K et al (2022) Cathepsin K regulates the tumor growth and metastasis by IL-17/CTSK/EMT axis and mediates M2 macrophage polarization in castration-resistant prostate cancer. Cell Death Dis 13(9):813. https://URL.org/10.1038/s41419-022-05215-8

Article  PubMed  PubMed Central  Google Scholar 

Zhu L, Zeng Q, Wang J, Deng F, Jin S (2023) Cathepsin V drives lung cancer progression by shaping the immunosuppressive environment and adhesion molecules cleavage. Aging 15(23):13961–13979. https://URL.org/10.18632/aging.205278

Article  PubMed  PubMed Central  Google Scholar 

Wang Y, Mei J, Zhang Y et al (2022) Cathepsin F genetic mutation is associated with familial papillary thyroid cancer. Am J Med Sci 364(4):414–424. https://URL.org/10.1016/j.amjms.2022.03.017

Article  PubMed  Google Scholar 

Tan J, Qian X, Song B et al (2018) Integrated bioinformatics analysis reveals that the expression of cathepsin S is associated with lymph node metastasis and poor prognosis in papillary thyroid cancer. Oncol Rep 40(1):111–122. https://URL.org/10.3892/or.2018.6428

PubMed  PubMed Central  Google Scholar 

Kim EK, Song MJ, Jang HH, Chung YS (2020) Clinicopathologic Analysis of Cathepsin B as a prognostic marker of thyroid Cancer. Int J Mol Sci 21(24). https://URL.org/10.3390/ijms21249537

Skrivankova VW, Richmond RC, Woolf BAR et al (2021) Strengthening the reporting of Observational studies in Epidemiology using mendelian randomization: the STROBE-MR Statement. JAMA 326(16):1614–1621. https://URL.org/10.1001/jama.2021.18236

Article  PubMed  Google Scholar 

Boehm FJ, Zhou X (2022) Statistical methods for mendelian randomization in genome-wide association studies: a review. Comput Struct Biotechnol J 20:2338–2351. https://URL.org/10.1016/j.csbj.2022.05.015

Article  PubMed  PubMed Central  Google Scholar 

Emdin CA, Khera AV, Kathiresan S (2017) Mendelian randomization. JAMA 318(19):1925–1926. https://URL.org/10.1001/jama.2017.17219

Article  PubMed  Google Scholar 

Zheng J, Baird D, Borges MC et al (2017) Recent developments in mendelian randomization studies. Curr Epidemiol Rep 4(4):330–345. https://URL.org/10.1007/s40471-017-0128-6

Article  PubMed  PubMed Central  Google Scholar 

Kurki MI, Karjalainen J, Palta P et al (2023) FinnGen provides genetic insights from a well-phenotyped isolated population. Nature 613(7944):508–518. https://URL.org/10.1038/s41586-022-05473-8

Article  PubMed  PubMed Central  Google Scholar 

Sun BB, Maranville JC, Peters JE et al (2018) Genomic atlas of the human plasma proteome. Nature 558(7708):73–79. https://URL.org/10.1038/s41586-018-0175-2

Article  PubMed  PubMed Central  Google Scholar 

Burgess S, Butterworth A, Thompson SG (2013) Mendelian randomization analysis with multiple genetic variants using summarized data. Genet Epidemiol 37(7):658–665. https://URL.org/10.1002/gepi.21758

Article  PubMed  PubMed Central  Google Scholar 

Bowden J, Davey Smith G, Burgess S (2015) Mendelian randomization with invalid instruments: effect estimation and bias detection through Egger regression. Int J Epidemiol 44(2):512–525. https://URL.org/10.1093/ije/dyv080

Article  PubMed  PubMed Central  Google Scholar 

Bowden J, Davey Smith G, Haycock PC, Burgess S (2016) Consistent estimation in mendelian randomization with some Invalid instruments using a weighted median estimator. Genet Epidemiol 40(4):304–314. https://URL.org/10.1002/gepi.21965

Article  PubMed  PubMed Central  Google Scholar 

Davey Smith G, Hemani G (2014) Mendelian randomization: genetic anchors for causal inference in epidemiological studies. Hum Mol Genet 23(R1):R89–98. https://URL.org/10.1093/hmg/ddu328

Article  PubMed  PubMed Central  Google Scholar 

Hartwig FP, Davey Smith G, Bowden J (2017) Robust inference in summary data mendelian randomization via the zero modal pleiotropy assumption. Int J Epidemiol 46(6):1985–1998. https://URL.org/10.1093/ije/dyx102

Article  PubMed  PubMed Central  Google Scholar 

Yang Y, Ma X, Pang W, Jiang C (2023) Causal associations of PM2.5 and GDM: a two-sample mendelian randomization study. Toxics 11(2). https://URL.org/10.3390/toxics11020171

Yavorska OO, Burgess S (2017) MendelianRandomization: an R package for performing mendelian randomization analyses using summarized data. Int J Epidemiol 46(6):1734–1739. https://URL.org/10.1093/ije/dyx034

Article  PubMed  PubMed Central  Google Scholar 

Verbanck M, Chen CY, Neale B, Do R (2018) Detection of widespread horizontal pleiotropy in causal relationships inferred from mendelian randomization between complex traits and diseases. Nat Genet 50(5):693–698. https://URL.org/10.1038/s41588-018-0099-7

Article  PubMed  PubMed Central  Google Scholar 

Breznik B, Motaln H, Lah Turnsek T (2017) Proteases and cytokines as mediators of interactions between cancer and stromal cells in tumours. Biol Chem 398(7):709–719. https://URL.org/10.1515/hsz-2016-0283

Article  PubMed  Google Scholar 

Salardani M, Barcick U, Zelanis A (2023) Proteolytic signaling in cancer. Expert Rev Proteom 20(12):345–355. https://URL.org/10.1080/14789450.2023.2275671

Article  Google Scholar 

Soond SM, Kozhevnikova MV, Frolova AS et al (2019) Lost or forgotten: the nuclear cathepsin protein isoforms in cancer. Cancer Lett 462:43–50.